Skip to content

A brief history of ‘new psychoactive substances’

Leslie A. King, Andrew T. Kicman

Drug Testing and Analysis July 1, 2011 DOI: 10.1002/dta.319 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Commentary Peer reviewed
Keywords Psychoactive substance Street drugs Pharmacology Medical emergency
Citations 99
Key points The text defines 'new psychoactive substances' as narcotic or psychotropic drugs not scheduled under the UN 1961 or 1971 Conventions but which may pose a public health threat comparable to scheduled substances, and notes that European Community Council Decision 2005/387/JHA superseded the earlier 'Joint Action on New Synthetic Drugs' in place since 1997.

Abstract

This special issue of DTA is devoted to what were once known as 'designer drugs', but in recent times have been described informally as 'legal highs'. The preferred term, as adopted by the European Community in 2005[1], [2] is 'new psychoactive substances'. They are defined as 'Narcotic or psychotropic drugs that are not scheduled under the United Nations 1961 or 1971 Conventions, but which may pose a threat to public health comparable to scheduled substances'. Council Decision 2005/387/JHA superseded an earlier arrangement, known as the 'Joint Action on New Synthetic Drugs' that had been in operation since 1997.

Citations in the library